Posted by Michael Wonder on 20 Jul 2021
Landmark PBS listing for Australians with bowel cancer
20 July 2021 - The Australian Government is providing access to a new treatment through the Pharmaceutical Benefits Scheme to support around Australians who are diagnosed with colorectal cancer, a type of bowel cancer.
For the first time, Keytruda (pembrolizumab) will have its listing extended on the PBS to include the treatment of unresectable or metastatic mismatch repair deficient colorectal cancer.
